Avalanche Hit With 2nd Stock Drop Suit Over Eye Drug Study
Avalanche Biotechnologies Inc. was hit with a putative class action in California federal court Monday for allegedly misleading shareholders to drive sales before and after its initial public offering, the second...To view the full article, register now.
Already a subscriber? Click here to view full article